Prostate cancer screening (PSA)
What the major U.S. guidelines recommend, with a link to verify each at the source. A quick-reference summary for clinicians, not medical advice.
USPSTF · 2018 · Grade C/D
Ages 55–69: individual decision (shared decision-making, Grade C). Age ≥70: do not screen (Grade D).
Verify at USPSTF →AUA / SUO · 2026
Shared decision-making for PSA screening; offer regular screening ages 50–69 (q2–4y). Baseline PSA at 45–50; begin at 40–45 if higher risk (Black, germline mutation, strong family history). 2026 amendment kept 2023 screening ages/interval.
Verify at AUA / SUO →